Whitehawk Therapeutics (WHWK) Free Cash Flow: 2018-2025
Historic Free Cash Flow for Whitehawk Therapeutics (WHWK) over the last 8 years, with Sep 2025 value amounting to -$15.4 million.
- Whitehawk Therapeutics' Free Cash Flow rose 3.13% to -$15.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$96.0 million, marking a year-over-year decrease of 70.12%. This contributed to the annual value of -$61.2 million for FY2024, which is 3.82% up from last year.
- According to the latest figures from Q3 2025, Whitehawk Therapeutics' Free Cash Flow is -$15.4 million, which was up 70.96% from -$53.0 million recorded in Q2 2025.
- Whitehawk Therapeutics' 5-year Free Cash Flow high stood at $10.6 million for Q1 2021, and its period low was -$53.0 million during Q2 2025.
- Moreover, its 3-year median value for Free Cash Flow was -$15.4 million (2025), whereas its average is -$18.7 million.
- Its Free Cash Flow has fluctuated over the past 5 years, first soared by 368.11% in 2021, then plummeted by 446.07% in 2025.
- Whitehawk Therapeutics' Free Cash Flow (Quarterly) stood at -$12.5 million in 2021, then rose by 8.71% to -$11.4 million in 2022, then rose by 8.15% to -$10.5 million in 2023, then crashed by 45.69% to -$15.2 million in 2024, then climbed by 3.13% to -$15.4 million in 2025.
- Its Free Cash Flow was -$15.4 million in Q3 2025, compared to -$53.0 million in Q2 2025 and -$12.4 million in Q1 2025.